Longevitys first blockbuster drug is hiding in plain sight
The longer the dissolved medication stays in contact with the oral mucosa, the more opportunity there is for absorption through the sublingual and buccal tissues
Compounded products must instead meet applicable 503A (patient-specific) or 503B (outsourcing facility) requirements and should be prescribed based on individualized clinical need
According to an Indian Council of Medical Research (ICMR) PCOS Task Force study published in JMIR Public Health and Surveillance, obesity is becoming increasingly common among Indian women, particularly those living in urban areas (3 Trusted Source Prevalence, Regional Variations, and Predictors of Overweight, Obesity, and Hypertension Among Healthy Reproductive-Age Indian Women: Nationwide Cross-Sectional Polycystic Ovary Syndrome Task Force Study Go to source)
The paper suggests initiating therapy at roughly 1025% of standard starting dose for type 2 diabetes or obesity, which for tirzepatide (approved starting dose 2.5 mg) would be roughly 250625 g, or 0.25 0.625 mg
The most common side effects reported with GLP-1 receptor agonists include nausea, vomiting, constipation, and mild digestive discomfort, particularly during the dose escalation phase